{"organizations": [], "uuid": "41004274639c560e6c3d54f4f6309d5d56bd1b7e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/hlundbeck-results/lundbecks-q4-operating-profit-below-expectations-idUSL8N1PW58U", "country": "US", "domain_rank": 408, "title": "Lundbeck's Q4 operating profit below expectations", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-07T15:10:00.000+02:00", "replies_count": 0, "uuid": "41004274639c560e6c3d54f4f6309d5d56bd1b7e"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/hlundbeck-results/lundbecks-q4-operating-profit-below-expectations-idUSL8N1PW58U", "ord_in_thread": 0, "title": "Lundbeck's Q4 operating profit below expectations", "locations": [], "entities": {"persons": [{"name": "drugmaker lundbeck", "sentiment": "negative"}, {"name": "lundbeck", "sentiment": "negative"}, {"name": "teis jensen", "sentiment": "none"}, {"name": "louise heavens", "sentiment": "none"}, {"name": "kare schultz", "sentiment": "none"}], "locations": [{"name": "copenhagen", "sentiment": "none"}, {"name": "israel", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "teva", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "COPENHAGEN, Feb 7 (Reuters) - Drugmaker Lundbeck’s fourth-quarter operating profit came in at 932 million Danish crowns ($155.19 million), undershooting the 1.05 billion expected by analysts in a Reuters poll.\nThe Danish company, which makes medicine for psychiatric and neurological disorders, has been looking for a new permanent chief executive since Israel’s Teva poached Kare Schultz last September.\nLundbeck expects revenue of 17.2-18.0 billion crowns in 2018, compared with the 17.86 billion forecast by analysts, and an operating profit of 4.8-5.2 billion crowns, compared with the 4.85 billion forecast in a Reuters’ poll.\n$1 = 6.0054 Danish crowns Reporting by Teis Jensen, editing by Louise Heavens\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-07T15:10:00.000+02:00", "crawled": "2018-02-09T06:08:42.000+02:00", "highlightTitle": ""}